(February 03 22:36) Forbes.com
Amazon is adding RxPass to its pharmacy footprint. Purportedly, it’s competing with Mark Cuban’s Cost Plus Drug Company (MCCPDC). But, limitations suggest it isn’t yet a real competitor.
You can find the original article
here